Lyell Immunopharma, Inc. — 10-Q Filings
14 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Lyell Immunopharma, Inc. (LYEL), sorted by most recent first. Each row links to the full filing on EdgarLookup. Lyell Immunopharma, Inc. has filed 14 10-Q documents with the SEC since 2020. To view all SEC filings by Lyell Immunopharma, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001628280-25-051619 | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0001806952-25-000008 | Aug 12, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0001628280-25-025135 | May 13, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0001628280-24-046285 | Nov 7, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0001628280-24-035617 | Aug 7, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0001628280-24-020467 | May 6, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0001628280-23-037360 | Nov 7, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0001628280-23-028215 | Aug 8, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0001628280-23-015765 | May 4, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0001628280-22-028929 | Nov 8, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0001628280-22-021109 | Aug 4, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0001628280-22-013611 | May 10, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0000950170-21-004270 | Nov 12, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0000950170-21-001389 | Aug 12, 2021 | Jun 30, 2021 |